Synthesis, pharmacological evaluation and electrochemical studies of novel 6-nitro-3,4-methylenedioxyphenyl-N-acylhydrazone derivatives: Discovery of LASSBio-881, a new ligand of cannabinoid receptors
作者:Carolina D. Duarte、Jorge L.M. Tributino、Daniel I. Lacerda、Marina V. Martins、Magna S. Alexandre-Moreira、Fernando Dutra、Etelvino J.H. Bechara、Francine S. De-Paula、Marilia O.F. Goulart、Juliano Ferreira、João B. Calixto、Marise P. Nunes、Alvaro L. Bertho、Ana Luisa P. Miranda、Eliezer J. Barreiro、Carlos A.M. Fraga
DOI:10.1016/j.bmc.2007.01.013
日期:2007.3
the discovery of LASSBio-881 (3c) as a novel in vivo antinociceptive, anti-inflammatory, and in vitro antiproliferative and antioxidant compound, with a cannabinoid ligand profile. We observed that LASSBio-881 (3c) was able to bind to CB1 receptors (71% at 100microM) and also to inhibit T-cell proliferation (66% at 10microM) probably by binding to CB2 receptors, in a non-proapoptotic manner, different
我们在这里描述了LASSBio-881(3c)作为具有大麻素配体特征的新型体内抗伤害性,抗炎性和体外抗增殖和抗氧化剂化合物的发现。我们观察到LASSBio-881(3c)能够以非促凋亡的方式结合CB2受体,从而能够结合CB1受体(在100microM时为71%),并且还可以抑制T细胞增殖(在10microM时为66%),与anandamide(1)不同。还证明了LASSBio-881(3c)对自由基(DPPH和羟基)具有重要的抗氧化特性,这可能是由于其特定的氧化还原行为,这反映了硝基和3,5-二叔丁基的存在循环伏安法研究证明了-4-羟苯基亚基。此外,